IMMUNE BIOSOLUTIONS
They are founded in 2012 by three entrepreneurial scientists, hoping to devise a full-proof platform for the discovery of clinically-relevant antibodies. Over the years, they have been supported by many prestigious entrepreneurship and scientific awards to create our Nebula Antibody platform and have substantiated this platform through several collaborations with various North American and European pharmaceutical partners. We have also produced over 350 commercial antibodies and submitted several patents for our technologies. In 2015, they took the bold step of initiating their own antibody pipeline, with a primary focus on cancer and gastrointestinal health. Thus far we have advanced 4 candidates to late stages of discovery.
IMMUNE BIOSOLUTIONS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2012-01-01
Address:
Sherbrooke, Quebec, Canada
Country:
Canada
Website Url:
http://www.immunebiosolutions.com
Total Employee:
11+
Status:
Active
Contact:
1-819-564-5283
Email Addresses:
[email protected]
Total Funding:
11.05 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon WordPress Font Awesome Apache Sitelinks Search Box Yoast WordPress SEO Plugin Yoast SEO Premium
Similar Organizations
Accent Therapeutics
Accent Therapeutics is a biopharmaceutical company.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Symphony Evolution
Symphony Evolution is a biopharmaceutical company.
Current Employees Featured
Founder
Investors List
Strategic Innovation Fund (SIF)
Strategic Innovation Fund (SIF) investment in Grant - Immune Biosolutions
Anges Quebec
Anges Quebec investment in Seed Round - Immune Biosolutions
Economic Development of Canada
Economic Development of Canada investment in Debt Financing - Immune Biosolutions
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-02 | Appointment of Luc Paquet as Chief Executive Officer - Immune Biosolutions enters into a new chapter of its growth Français |
Official Site Inspections
http://www.immunebiosolutions.com
- Host name: 172.67.201.226
- IP address: 172.67.201.226
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
